news Heparin inhibits SARS-CoV-2 invasion, finds study 29 January 2021 | By Hannah Balfour (Drug Target Review) Research suggests heparin could be repurposed for COVID-19 because it can bind to the SARS-CoV-2 Spike protein and prevent the virus from infecting cells in vitro.
news T-cell exhaustion may limit long-term immunity in COVID-19 patients 22 January 2021 | By Hannah Balfour (Drug Target Review) Researchers suggest patients who develop mild COVID-19 may not be able to fight reinfection very effectively because their CD8+ T cells show signs of exhaustion.
news A novel drug target for viral encephalitis therapies 17 September 2020 | By Hannah Balfour (Drug Target Review) Researchers showed CXCL1 signalling to neutrophils drove brain inflammation in herpes simplex virus (HSV) encephalitis and blocking the protein resulted in less severe disease.
news Robot researcher discovers new highly active catalyst 9 July 2020 | By Hannah Balfour (Drug Target Review) The autonomous robot scientist can independently perform experimental procedures and makes its own decisions about which tests to perform.
news New drug could be used for targeted cancer therapies 7 August 2019 | By Rachael Harper (Drug Target Review) A new drug called IP1867B, which could be used for future treatments of brain tumours, is being examined.
